Recently, Dorayshield's foreign trade business achieved another significant success—the successful delivery of a batch of tungsten alloy vial shields to a Norwegian medical equipment supplier. The successful completion of this order not only expands the company's medical radiation protection products into the Nordic market but also demonstrates the reliability of its products in the international nuclear medicine field, building a solid bridge for deepening medical equipment trade cooperation between China and Norway.
Tungsten alloy vial shields are essential protective equipment for storing radiopharmaceuticals and samples in nuclear medicine. Their core advantage lies in their use of high-density tungsten alloy, which offers far superior radiation shielding efficiency than traditional lead containers. They effectively prevent radioactive material leakage, ensuring the safety of medical personnel, the environment, and the public. Furthermore, the vials are designed to balance sealing and portability. They feature a dedicated sealing cap to prevent evaporation of the drug solution, and the bottle neck is compatible with common medical syringes for easy clinical use. They are also lead-free and fully meet the environmental and safety requirements of modern medicine. The Norwegian healthcare system is renowned worldwide for its high standards and stringent safety standards, placing extremely high demands on the performance, compliance, and environmental performance of medical protective equipment. The medical equipment supplier we partnered with has deep roots in the local nuclear medicine equipment market, with products supplied to the nuclear medicine departments of numerous Norwegian hospitals. The selection of protective equipment requires multiple rounds of radiation shielding testing, biosafety audits, and environmental certifications.
This collaboration with Norway is more than just a simple trade export; it is a comprehensive test of Dorayshield's R&D, production, and quality control systems. The company strictly adheres to international medical device standards, ensuring consistent quality control throughout the entire product process, from material traceability to finished product shipment, meeting the stringent quality requirements of European customers.
The successful export of tungsten alloy vial shields to Norway marks another significant breakthrough for Dorayshield in the international market. It not only creates a new growth area for the company but also further enhances its visibility and influence in the international medical equipment accessories sector. In the future, Dorayshield will continue to uphold the concept of "quality first, customer first", continuously innovate and improve product quality, strengthen cooperation with global customers, and contribute more to the development of the medical industry.
